These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35124191)

  • 1. Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases.
    Izco M; Carlos E; Alvarez-Erviti L
    Neurobiol Dis; 2022 May; 166():105651. PubMed ID: 35124191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.
    Teixeira M; Sheta R; Idi W; Oueslati A
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders.
    Miranda AM; Di Paolo G
    Cell Stress; 2018 May; 2(5):115-118. PubMed ID: 31225476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.
    Qureshi YH; Baez P; Reitz C
    Mol Cell Biol; 2020 Sep; 40(19):. PubMed ID: 32690545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPMLs and TPCs: Targets for lysosomal storage and neurodegenerative disease therapy?
    Krogsaeter E; Rosato AS; Grimm C
    Cell Calcium; 2022 May; 103():102553. PubMed ID: 35144097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The multiple roles of exosomes in Parkinson's disease: an overview.
    Porro C; Panaro MA; Lofrumento DD; Hasalla E; Trotta T
    Immunopharmacol Immunotoxicol; 2019 Aug; 41(4):469-476. PubMed ID: 31405314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy.
    Izco M; Carlos E; Alvarez-Erviti L
    Neuroscientist; 2022 Apr; 28(2):180-193. PubMed ID: 33530851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
    Shacka JJ; Roth KA; Zhang J
    Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
    Gao S; Casey AE; Sargeant TJ; Mäkinen VP
    Brain; 2018 Sep; 141(9):2711-2720. PubMed ID: 30124770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease.
    He A; Wang M; Li X; Chen H; Lim K; Lu L; Zhang C
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype.
    Mamais A; Wallings R; Rocha EM
    Handb Clin Neurol; 2023; 193():33-51. PubMed ID: 36803821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes in Vascular/Neurological Disorders and the Road Ahead.
    Alzahrani FA; Riza YM; Eid TM; Almotairi R; Scherschinski L; Contreras J; Nadeem M; Perez SE; Raikwar SP; Jha RM; Preul MC; Ducruet AF; Lawton MT; Bhatia K; Akhter N; Ahmad S
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the endolysosomal pathway and exosome release in tau propagation.
    Yan M; Zheng T
    Neurochem Int; 2021 May; 145():104988. PubMed ID: 33582164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration.
    Quiroz-Baez R; Hernández-Ortega K; Martínez-Martínez E
    Front Neurol; 2020; 11():580030. PubMed ID: 33362690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are exosomes the vehicle for protein aggregate propagation in neurodegenerative diseases?
    Lim YJ; Lee SJ
    Acta Neuropathol Commun; 2017 Aug; 5(1):64. PubMed ID: 28851422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers.
    Herman M; Randall GW; Spiegel JL; Maldonado DJ; Simoes S
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220387. PubMed ID: 38368936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endolysosomal dysfunction in Parkinson's disease: Recent developments and future challenges.
    Kett LR; Dauer WT
    Mov Disord; 2016 Oct; 31(10):1433-1443. PubMed ID: 27619535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of extracellular vesicles in neurodegenerative diseases.
    Quek C; Hill AF
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1178-1186. PubMed ID: 27659705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Evidence for Endolysosomal Dysfunction in Parkinson's Disease: A Critical Overview.
    Yahya V; Di Fonzo A; Monfrini E
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.